Lymphoma Cancer
Cancer vaccine for lymphoma following chemotherapy - Clinical Trial Review - Brief Article This study is currently recruiting patients.
Sponsored by National Cancer Institute (NCI)
This study will evaluate the effectiveness of an experimental cancer vaccine for lymphoma. Although currently available lymphoma treatments (radiation therapy and various chemotherapy regimens) may cause a remission of disease, none provides a longterm survival.
Condition Treatment or Intervention Phase
B Cell Lymphoma Drug: Id-KLH Vaccine Phase III
Follicular Lymphoma Drug: GM-CSF
Study ID Numbers: 000050; 00-C-0050 NLM Identifier: NCT00001945
COPYRIGHT 2003 Journal of Drugs in Dermatology
COPYRIGHT 2003 Gale Group
|
